Authors: Tumas, DB Chan, B Werther, W Wrin, T Vennari, J Desjardin, N Shields, RL Jardieu, P

Citation: Db. Tumas et al., Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization, J ALLERG CL, 107(6), 2001, pp. 1025-1033

Authors: Deeks, SG Wrin, T Liegler, T Hoh, R Hayden, M Barbour, JD Hellmann, NS Petropoulos, CJ McCune, JM Hellerstein, MK Grant, RM

Citation: Sg. Deeks et al., Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia., N ENG J MED, 344(7), 2001, pp. 472-480

Authors: Petropoulos, CJ Parkin, NT Limoli, KL Lie, YS Wrin, T Huang, W Tian, H Smith, D Winslow, GA Capon, DJ Whitcomb, JM

Citation: Cj. Petropoulos et al., A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1, ANTIM AG CH, 44(4), 2000, pp. 920-928

Authors: Berman, PW Huang, W Riddle, L Gray, AM Wrin, T Vennari, J Johnson, A Klaussen, M Prashad, H Kohne, C DeWit, C Gregory, TJ

Citation: Pw. Berman et al., Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand, VIROLOGY, 265(1), 1999, pp. 1-9

Authors: Cleland, JL Lim, A Daugherty, A Barron, L Desjardin, N Duenas, ET Eastman, DJ Vennari, JC Wrin, T Berman, P Murthy, KK Powell, MF

Citation: Jl. Cleland et al., Development of a single-shot subunit vaccine for HIV-1. 5. Programmable invivo autoboost and long lasting neutralizing response, J PHARM SCI, 87(12), 1998, pp. 1489-1495